Crane Worldwide strengthens its supply chain solutions for the fast and safe delivery of the COVID-19 vaccine.
FREMONT, CA: With the latest announcements that pharmaceutical companies are close to supplying an initial vaccine to combat the COVID-19 virus around the world, global logistics experts are stepping up to help what will be an epic supply chain hurdle.
Crane Worldwide documents, tests, verify and validates the most rigorous needs known about the vaccine. Not only investing in temperature-controlled equipment, but heavily capitalizing on visibility and monitoring systems that will be used to offer end-to-end record keeping to meet industry and regulatory compliance, allow enhanced security, and provide the utmost quality assurance to international vaccine manufacturers.
An escalated process of offering a regulated vaccine to market has spearheaded a fast race by pharmaceutical firms to present a successful pandemic solution. As the world watches closely, supply chain experts are using their knowledge and expertise. They will play a vital role in distribution strategies to provide the vaccine to end-users in rural and city locations.
Supply chain challenges are evident as more data becomes available about a viable vaccine. The exact temperature control requirements, the number of doses needed, the shelf life, the additional product specifications, and the packaging needs are still largely unknown. Specific supply chain solutions encompassing the storage, international/domestic transportation, and final mile distribution means of the COVID vaccine will hinge upon the pioneering pharmaceutical companies' final product specification that could include temperatures as cold as -70C.
Supply chain partnerships will be a vital success factor in distributing the COVID vaccine to communities all over the world. Building on the intelligence and research available to date, Crane has tested and verified many supply chain scenarios that will support and supplement the success of the vaccine supply chain, including storage capabilities, ground transportation, and local/international transportation needs.
Crane Worldwide believes that it is the company's moral duty, as a 3PL partner, to ensure that it has solid solutions in place when the vaccine is released. With a partnership approach, Crane will provide flexibility and make further investments to support its clients' supply chain constraints both now and in the future.